Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Accumulated Depreciation (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Accumulated Depreciation for 2 consecutive years, with $838000.0 as the latest value for Q3 2023.

  • Quarterly Accumulated Depreciation fell 66.81% to $838000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $838000.0 through Sep 2023, down 66.81% year-over-year, with the annual reading at $3.2 million for FY2022, N/A changed from the prior year.
  • Accumulated Depreciation for Q3 2023 was $838000.0 at LENZ Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $3.9 million in Q1 2023, with the low at $838000.0 in Q3 2023.